Studies of MHWs, (social workers, social auxiliary workers, trauma counsellors, and telephone counsellors), who work with trauma and stress, often focus on pathological symptoms and on the need to develop psycho-education programmes (Figley, 2002; Johnson & Hunter, 1997; Mac Ritchie & Leibowitz, 2010; Mikulincer, 1994; Stiles, 2002). A gap was identified how MHWs, who continuously intervene with traumatised children, cope with the stressors associated with their work. The purpose of this research was to explore the coping strategies of Mental Health Workers (MHWs) exposed to Secondary Trauma (ST)as a result of having to deal day to day with children (younger than 18) who have experienced trauma, including sexual, physical and emotional abuse, as well as the witness of violence. The MHWs’ coping responses were investigated using a qualitative case study approach. The investigation showed how MHWs constructed their realities by examining their coping strategies and the individual meanings they assigned to these. A convenience sample, based on the availability of participants, was selected. Nine women and one man, ranging in age from 26 to 57 years, employed at Childline Gauteng, participated in the research. The Mmogo-Method®, a projective visual research technique, explored the MHWs’ coping experiences through qualitative data collection methods. Visual and textual data were gathered and analysed thematically. It was found that the MHWs at Childline Gauteng displayed two main coping styles, namely intrapersonal and relational coping strategies. In the face of their daily stressors, MHWs managed to cope successfully by using strategies that are embedded in their daily activities. Their ability to find alternative ways to cope, despite continuous exposure to children’s trauma, allowed the MHWs to fulfil their work obligations. Their intrapersonal coping strategies reflected an ability to draw on their inner resources. Being aware of their environment and how it affects them, MHWs were able to regulate themselves and their environments by adopting positive attitudes. These attitudes, and the MHWs’ dispositions, positively affected their outlook on life. Moreover, MHWs maintained a healthy distance from their stressful environment by means of meaningful disengagement. Meaningful disengagement was fundamental to creating solitude as a coping strategy. Personal and professional boundaries, self-care and being able to draw on spirituality were further coping resources. MHWs’ discussions about finding meaning in their work revealed that they would not be able to do their work if they did not experience it as spiritually significant. Drawing on external resources, relational coping strategies included supportive relationships with family, friends and colleagues. Reciprocal unconditional acceptance significantly contributed to coping because it was important for MHWs to experience family and friends' attitudes as supportive and non-judgemental. MHWs encountered an organisational culture of care in the form of freedom to interact with colleagues and managers and sharing experiences. This interaction contributed to successful coping because MHWs felt comfort in the knowledge that they were not alone when dealing with children's trauma. This interaction facilitated coping because MHWs were able to interface successfully with their environment, even in difficult circumstances. In conclusion, the MHWs provided nuanced descriptions of the ways in which they experienced coping strategies. They coped with the demands of their profession by using internal and external resources, including intrapersonal and relational coping. / MA (Research Psychology), North-West University, Potchefstroom Campus, 2014

<p>Predmet ove doktorske disertacije je definisanje metoda i procedure<br />za procenu veka konstrukcije tornja postrojenja za istraživanje nafte<br />i gasa. Dati su rezultati eksperimentalnih istraživanja radi analize<br />otpornosti prema prslinama pri statičkom i pri promenljivom<br />opterećenju eksploatisanog i novog materijala konstrkcije tornja<br />postrojenja za istraživanje nafte i gasa.</p> / <p>The topic of this doctoral dissertation is definition methods and proceduries for an<br />analysis of an assessmen life of construction derrick plant for investigation oil<br />and gas. The results of experimental investigation performed for the analysis<br />of crack resistance under static and under variable loading eksploatacion<br />and new of materials of construction derrick plant for investigation oil and gas.</p>

<p>U radu su istražene mogućnosti za razvoj modela za izbor<br />lokacije proizvodnih sistema. Razvijen je model za izbor<br />lokacije proizvodnih sistema i verifikovan u studiji<br />slučaja na teritoriji AP Vojvodine i opštine Inđija.<br />Posebno značajan rezultat je fazi ekspertni sistem za<br />analizu kriterijuma odlučivanja, geografski informacioni<br />sistem za skrining i prostorni sistem za podršku u izboru<br />lokacije proizvodnih sistema.</p> / <p>This paper examines the possibilities of model development for<br />production systems site selection. Developed model for production<br />systems site selection is presented and tested in case study of AP<br />Vojvodina and Indjija municipality. A particularly important result is<br />developed fuzzy expert system for factor analysis, geographic<br />information system for screening and spatial decision support system.</p>

<p>Uvod: Hirur&scaron;ko lečenje nodozne bolesti &scaron;titaste žlezde predstavlja jednu od najče&scaron;će izvođenih operacija u endokrinoj hirurgiji. Pored klasičnih hirur&scaron;kih metoda, poslednjih godina su se pojavile različite tehnike minimalno invazivne tireoidektomije kao rezultat sveukupnog trenda razvoja minimalno invazivnih hirur&scaron;kih tehnika. Kliničke indikacije i prednosti izvođenja minimalno invazivne video-asistirane tiroidektomije (MIVAT) u odnosu na klasičnu hirur&scaron;ku tehniku u lečenju nodozne bolesti &scaron;titaste žlezde su i dalje nedovoljno definisane i u fokusu su savremenih istraživanja. Cilj istraživanja je procena učestalosti komplikacija (intraoperativno i postoperativno krvarenje, pareza i paraliza laringealnog živca, hipoparatireoidizam) tokom i nakon minimalno invazivne tireoidektomije u nodoznim benignim oboljenjima &scaron;titaste žlezde uz poređenje sa klasičnom tireoidektomijom, da se ispita intenzitet postoperativnog bola, merenjem pomoću vizuelno analogne skale tokom sedam postoperativnih dana, nakon minimalno invazivne tireoidektomije u nodoznim benignim oboljenjima &scaron;titaste žlezde uz poređenje sa klasičnom tireoidektomijom, kao i da se ispita dužina bolničkog boravka nakon minimalno invazivne tireoidektomije u nodoznim benignim oboljenjima &scaron;titaste žlezde uz poređenje sa klasičnom tireoidektomijom. Metodologija: Ispitivanje je sprovedeno kao prospektivna, kontrolisana randomizirana studija, u trajanju od novembra 2014. do aprila 2016. godine i obuhvatila je analizu 100 pacijenata operisanih na Klinici za grudnu hirurgiju Instituta za plućne bolesti Vojvodine zbog nodozne bolesti &scaron;titaste žlezde. Svi ispitanici su podeljeni u dve osnovne grupe u odnosu na operativnu tehniku: klasična metoda (KM) i minimalno invazivna videoasistirana metoda (MIVAM). Faze u toku ispitivanja su obuhvatile: analizu podataka o preoperativnim morfo-funkcionalnim dijagnostičkim testovima za nodoznu bolest &scaron;titaste žlezde (karakteristike ultrazvučnog nalaza nodozne promene i vrednosti volumena izmenjenog režnja &scaron;titaste žlezde), nalaz citolo&scaron;kog pregleda punktata tiroidnog nodusa dobijenog tankom iglom, laboratorijski pokazatelji poremećaja &scaron;titaste žlezde u cilju definisanja funkcionog stanja, odnosno postojanja autoimunog oboljenja &scaron;titaste žlezde; analizu perioperativnih karakteristika hirur&scaron;kih metoda [dužina incizije (cm), operativno vreme (min), težina odstranjenog patoanatomskog supstrata (gr), intraoperativni gubitak krvi (ml)], analiza ranih postoperativnih komplikacija (krvarenje i hematom, povreda donjeg rekurentnog laringealnog živca (nalaz direktne laringoskopije na kraju operacije), hipokalcemija, kolaps traheje, edem larinksa, serom, infekcija, dehiscencija], analiza nehirur&scaron;kih komplikacija, dužina hospitalizacije u danima, intenzitet i dužina trajanja postoperativnih bolova [(upotreba vizuelno analogne skale (VAS) bola 1, 2 i 7 postoperativnog dana)], kasne postoperativne komplikacije (6 meseci nakon operacije), stepen zadovoljstva esteskim rezultatom (anketa sprovedena na kontrolnom pregledu 6 meseci nakon operacije-kozmetski skor). Rezultati: U periodu izvođenja studije od novembra 2014. do aprila 2016. godine, nakon primene kriterijuma za uključivanje/isključivanje iz studije od 175 preostalo je 102 ispitanika, zbog patohistolo&scaron;kog nalaza maligniteta ex tempore biopsije kod jednog pacijenta, a kao i zbog intraoperativno uočenih izraženih adhezivnih promena kod jednog pacijenta urađena je konverzija, odnosno promena operativne tehnike minimalno invazivne u klasičnu metodu. U statističku obradu je uključeno ukupno 100 ispitanika podeljenih u dve grupe: grupu I bolesnika - KM (n = 50) i grupu II bolesnika - MIVAM (n = 50). U ispitivanje je ukupno uključeno 78 žena i 22 mu&scaron;karca. U odnosu na polnu strukturu u ispitivanim grupama nije uočena postojanje statistički značajne zastupljenosti u zastupljenosti mu&scaron;kog (p = 0,18), odnosno ženskog pola (p = 0,59). Takođe, uočeno je da među grupama ispitanika ne postoji statistički značajna razlika po godinama života (p = 0,16). Nije bilo statistički značajne razlike između ispitivanih grupa u odnosu na vrstu oboljenja &scaron;titaste žlezde i funkcioni status, kao ni u odnosu na ultrazvučne karakteristike solitarnog (dominantnog) nodusa kod ispitanika (veličine nodusa, ehogenost nodusa, ivica nodusa, kalcifikacija, vaskularizacije), u odnosu na citolo&scaron;ku dijagnozu aspirata uboda tankom iglom (benigni, neodgovarajući, sumnjivi), te u odnosu na volemn izmenjenog režnja. Analizom perioperativnih pokazatelja hirur&scaron;kih metoda u grupi MIVAM je utvrđena statički značajno manja dužina incije u odnosu na KM grupu (2,0 &plusmn; 0,5 cm vs. 7 &plusmn; 1,9 cm, p = 0,00), dok se težina patoanatomskog supstata (18,3 &plusmn; 6,4 vs. 19,6 &plusmn; 5,2 gr, p = 0,21), operativno vreme za izvođenje lobektomije (54 &plusmn; 14 vs. 61 &plusmn; 16 min, p = 0,25), odnosno operativno vreme za izvođenje tireoidektomije (72 &plusmn; 27 vs. 85 &plusmn; 24 min, p = 0,36) nisu statitički značajno razlikovali između ispitivanih grupa. U grupi MIVAM, rane postoperativne komplikacije (krvarenje, povreda donjeg rekurentnog laringealnog živca I hipokalcemija) su se javile kod 8% (4/50), a u KM grupi kod je 10% (5/50), &scaron;to nije bilo statistički značajno (p = 0,72). U odnosu na kasne postoperativne komplikacije, samo je kod jednog pacijenta iz MIVAM grupe registrovano postojanje keloida, dok se (trajni hipoparatiroidizam, recidivantni hipertiroidizam, reakcija na strano telo) nije zabeleženo. Nije uočena statistički značajna razlika (p &gt; 0,005 za sve) u zastupljenosti vrste nalaza patohistolo&scaron;kog pregleda odstranjenog supstrata (koloidna struma, folikularni adenoma, cista, papilarni karcinom i Hashimoto tiroiditis). Pacijenti iz MIVAM grupe statistički značajno imaju manji prosečan intenzitet bola po VAS skali u vremenskim intervalima nakon operacije 6h, 24h i 48 h (p &lt; 0,05, za sve). Ukupni kozmetski skor je bio statistički značajno vi&scaron;i u MIVAM grupi u odnosu na KM grupu (18,9 &plusmn; 1,4 vs. 15,8 &plusmn; 1,3, p = 0,00). Zaključci:Učestalost ranih postoperativnih komplikacija (intraoperativno i postoperativno krvarenje, pareza i paraliza laringealnog živca, hipokalcemija) je bez signifikantne razlike, praktično podjedanaka kod pacijenata operisanih minimalno invazivnom metodom u komparaciji sa klasičnom metodom. Prosečna dužina trajanja minimalno invazivne tireoidektomije i klasične tireoidektomije je bez signifikatne razlike, &scaron;to može govoriti o odgovarajućem nivou hirur&scaron;ke tehnike koji omogućava prednosti minimalne invazivnosti kao hirur&scaron;kog principa. Dužina hospitalizacije nakon minimalno invazivne tireoidektomije je značajno kraća u odnosu na klasičnu tireoidektomiju, &scaron;to značajno doprinosi sveukupnom oporavku pacijenta, a na taj način i tro&scaron;kovi lečenja se umanjuju.Primena minimalno invazivne tireoidektomije u odnosu na klasičnu tireoidektomiju, dovodi do smanjenja subjektivnog osećaja postoperativnog bola, u toku hospitalizacije (6 i 24 h), kao i sedam dana nakon intervencije. Kozmetski skor, kao pokazatelj zadovoljstva pacijenta sa izgledom ožiljka je statistički značano vi&scaron;i kod pacijenata koji su operisani minimalno invazivnom hirur&scaron;kom tehnikom u odnosu na pacijente koji su operisani klasičnom metodom, &scaron;to je u odnosu na predominantnu zastupljenost ženskog pola u ispitivanim grupama od posebnog značaja pri odabiru terapijskog tretmana. Prema rezultatima studije, nameće se opravdanost i potreba uvođenja minimalno invazivne tiroidektomije u standardnu kliničku praksu kao metode hirur&scaron;kog lečenja nodozne bolesti &scaron;titaste žlezde kod pacijenata sa urednim funkcionim statusom &scaron;titaste žlezde, kod kojih je veličina solitarnog/dominantnog nodusa do 35 mm.</p> / <p>INTRODUCTION: Surgical treatment of nodular thyroid disease is one of the most commonly performed procedures in endocrine surgery. In addition to traditional surgical methods, different techniques of minimally invasive thyreoid surgery have been developed. Clinical indications for the surgical treatment of nodular thyroid disease with minimally invasive video-assisted surgical technique are still insufficiently defined. The aim of the study was to estimate the incidence of complications (intraoperative and postoperative bleeding, paresis and paralysis of the laryngeal nerve, hypoparathyroidism) during and after minimally invasive thyroidectomy in benign nodular thyroid disease with a comparison with conventional thyroidectomy, to examine the intensity of postoperative pain, measured by a visual analog scale for seven postoperative days after surgery, as well as to examine the length of hospitalisation after minimally invasive thyroidectomy with a comparison with conventional thyroidectomy. METHODOLOGY: The study was conducted as a prospective, randomized controlled studies, from November 2014 to April 2016 and included the analysis of 100 patients operated at the Clinic for Thoracic Surgery, Institute for Pulmonary Diseases due to nodular thyroid disease. All subjects were divided into two basic groups according to the surgical technique: classical method (KM) and minimally invasive video-assisted method (MIVAM). Stages during the study included: analysis of data on preoperative morpho-functional diagnostic tests for thyroid disease (characteristic ultrasound findings, nodule caracteristics, volume of exchanged thyroid gland lobe), cytologic examination of aspirates of thyroid nodules obtained by fine needle, laboratory indicators of thyroid disorders gland in order to define the functional status and the presence of autoimmune thyroid disease; analysis of perioperative characteristics of surgical methods [incision length (cm), operative time (min), weight of removed pathoanatomic substrate (gr), intraoperative blood loss (ml)], the analysis of early postoperative complications (bleeding and hematoma, injury to lower recurrent laryngeal nerve (finding direct laryngoscopy at the end of the operation), hypocalcemia, the collapse of the trachea, laryngeal edema, seroma, infection, dehiscence] analysis nonsurgical complications, length of hospitalisation in hours, the intensity and duration of postoperative pain [(use of the visual analog scale (VAS) pain 1, 2 and 7 postoperative days)], late postoperative complications (6 months after surgery), the level of aesthetic satisfaction score (on control examination 6 months after surgery-cosmetic score). RESULTS: In the period of the study from November 2014 to April 2016, from 175 patients with nodular thyreoid disease 102 was observed after application of the inclusion/exclusion criteria. Since in the further analysis two patients was exluded (due to histological findings of malignancy ex tempore biopsy in one patient, and because of a perceived intraoperatively expressed adhesive changes in one patient underwent conversion) in statistical analysis patients were devided into two groups: group I patients - KM (n = 50) and group II patients - MIVAM (n = 50). The study included a total of 78 women and 22 men, it was observed that between the groups there was no statistically significant difference according to age (p = 0,16). There were no statistically significant differences between the groups in terms of the type of thyroid gland function and functional status, as well as in relation to the ultrasonographic characteristics of solitary (dominant) nodule in the subjects (the size of nodules, echogenicity nodes, the edge nodes, calcification, vascularization), the cytological diagnosis of fine needle aspiration puncture (benign, inappropriate, suspicious) and with respect to the lobe volume. The analysis of indicators of perioperative surgical methods in the group MIVAM was significantly smaller length compared to KM group (2,0 &plusmn; 0,5 cm vs. 7 &plusmn; 1,9 cm, p = 0,00), until the weight of pathoanatomic supstrate (18,3 6 &plusmn; 4 vs. 19 &plusmn; 6 5 2 g, p = 0,21), the operating time for performing a lobectomy (54 &plusmn; 14 vs. 61 &plusmn; 16 min, p = 0,25) or operative time to perform the surgery (72 &plusmn; 27 vs. 85 &plusmn; 24 min, p = 0,36) were not significantly different between the groups. The group MIVAM, early postoperative complications (bleeding, injury to the lower recurrent laryngeal nerve and hypocalcemia) occurred in 8% (4/50), and KM group in 10% (5/50), which was not statistically significant (p = 0,72). Compared to late postoperative complications, only one patient from group MIVAM registered the existence of keloids, while (permanent hypoparathyroidism, recurrent hyperthyroidism, a reaction to a foreign body) was not recorded. There was no statistically significant difference (p &gt; 0,005 for all) in the presence of histological types of findings review the removed substrate (colloid goiter, follicular adenoma, cysts, papillary carcinoma and Hashimoto&#39;s thyroiditis). Patients in MIVAM groups have significantly lower average pain intensity by VAS scale at intervals after surgery 6h, 24h and 48 h (p &lt; 0,05, for all). Total cosmetic score was significantly higher in MIVAM group compared to the KM group (18,9 &plusmn; 1,4 vs. 15,8 &plusmn; 1,3, p = 0,00). CONCLUSIONS: The incidence of early postoperative complications (intraoperative and postoperative bleeding, paresis and paralysis of the laryngeal nerve, hypocalcemia) were without significant differences between patients operated with minimally invasive method in comparison to the classical method. The average duration of minimally invasive thyroidectomy and classical thyroidectomy were without statistical significance difference, suggesting the appropriate level of surgical technique that enables the advantages of minimal invasiveness as surgical principles. Length of hospitalization after minimally invasive thyroidectomy was significantly shorter compared to conventional thyroidectomy, which significantly contributes to the overall recovery of the patient, lowering the cost of treatment. Minimally invasive thyroidectomy compared to conventional thyroidectomy, decreases the subjective feeling of postoperative pain, during hospitalization (6 and 24 h), as well as seven days after the intervention. In one-fifth of patients who underwent minimally invasive surgery method in the postoperative course of the subjective sensation of pain was not recorded. Cosmetic score as an indicator of patient satisfaction with the appearance of the scar was statistically higher in patients who underwent surgery less invasive surgical technique compared to patients who were operated by the classical method. According to the study, minimally invasive thyroidectomy has been demonstrated to be safe and superior to conventional open techniques for surgical treatment of nodular thyroid disease in patients with normal thyroid function with solitary/dominant nodule size &lt; 35 mm.</p>

<p><!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves/> <w:TrackFormatting/> <w:PunctuationKerning/> <w:ValidateAgainstSchemas/> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF/> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables/> <w:SnapToGridInCell/> <w:WrapTextWithPunct/> <w:UseAsianBreakRules/> <w:DontGrowAutofit/> <w:SplitPgBreakAndParaMark/> <w:DontVertAlignCellWithSp/> <w:DontBreakConstrainedForcedTables/> <w:DontVertAlignInTxbx/> <w:Word11KerningPairs/> <w:CachedColBalance/> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> <m:mathPr> <m:mathFont m:val="Cambria Math"/> <m:brkBin m:val="before"/> <m:brkBinSub m:val="&#45;-"/> <m:smallFrac m:val="off"/> <m:dispDef/> <m:lMargin m:val="0"/> <m:rMargin m:val="0"/> <m:defJc m:val="centerGroup"/> <m:wrapIndent m:val="1440"/> <m:intLim m:val="subSup"/> <m:naryLim m:val="undOvr"/> </m:mathPr></w:WordDocument></xml><![endif]--></p><p><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true" DefSemiHidden="true" DefQFormat="false" DefPriority="99" LatentStyleCount="267"> <w:LsdException Locked="false" Priority="0" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Normal"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 1"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/> <w:LsdException Locked="false" Priority="39" Name="toc 1"/> <w:LsdException Locked="false" Priority="39" Name="toc 2"/> <w:LsdException Locked="false" Priority="39" Name="toc 3"/> <w:LsdException Locked="false" Priority="39" Name="toc 4"/> <w:LsdException Locked="false" Priority="39" Name="toc 5"/> <w:LsdException Locked="false" Priority="39" Name="toc 6"/> <w:LsdException Locked="false" Priority="39" Name="toc 7"/> <w:LsdException Locked="false" Priority="39" Name="toc 8"/> <w:LsdException Locked="false" Priority="39" Name="toc 9"/> <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/> <w:LsdException Locked="false" Priority="10" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Title"/> <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/> <w:LsdException Locked="false" Priority="11" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/> <w:LsdException Locked="false" Priority="22" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Strong"/> <w:LsdException Locked="false" Priority="20" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/> <w:LsdException Locked="false" Priority="59" SemiHidden="false" UnhideWhenUsed="false" Name="Table Grid"/> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/> <w:LsdException Locked="false" Priority="1" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 1"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 1"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 1"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/> <w:LsdException Locked="false" Priority="34" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/> <w:LsdException Locked="false" Priority="29" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Quote"/> <w:LsdException Locked="false" Priority="30" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 1"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 1"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 2"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 2"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 2"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 2"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 2"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 3"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 3"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 3"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 3"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 3"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 4"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 4"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 4"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 4"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 4"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 5"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 5"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 5"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 5"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 5"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 6"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 6"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 6"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 6"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 6"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/> <w:LsdException Locked="false" Priority="19" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/> <w:LsdException Locked="false" Priority="21" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/> <w:LsdException Locked="false" Priority="31" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/> <w:LsdException Locked="false" Priority="32" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/> <w:LsdException Locked="false" Priority="33" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Book Title"/> <w:LsdException Locked="false" Priority="37" Name="Bibliography"/> <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/> </w:LatentStyles></xml><![endif]--><!--[if gte mso 10]><style> /* Style Definitions */ table.MsoNormalTable{mso-style-name:"Table Normal";mso-tstyle-rowband-size:0;mso-tstyle-colband-size:0;mso-style-noshow:yes;mso-style-priority:99;mso-style-qformat:yes;mso-style-parent:"";mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-para-margin-top:0in;mso-para-margin-right:0in;mso-para-margin-bottom:10.0pt;mso-para-margin-left:0in;line-height:115%;mso-pagination:widow-orphan;font-size:11.0pt;font-family:"Calibri","sans-serif";mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:"Times New Roman";mso-fareast-theme-font:minor-fareast;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;}</style><![endif]--></p><p class="MsoNormal" style="text-align:justify">Uvod: Aristolohična kiselina I je nefrotoksična i kancerogena supstanca koja je odgovorna za nefropatiju koja nastaje usled kori&scaron;ćenja herbalnih preparata i čajeva za mr&scaron;avljenje. S obzirom da se ova supstanca može naći u korovskim biljkama, smatra se jednim od glavnih ekotoksikolo&scaron;kih uzroka za nastanak balkanske endemske nefropatije čiji definitivan uzrok jo&scaron; uvek nije otkriven. Toksičnost ove supstance je dokazana na brojnim animalnim modelima, međutim mehanizmi koji dovode do o&scaron;tećenja bubrežnog parenhima jo&scaron; u potpunosti nisu razja&scaron;njeni.<span style="mso-spacerun:yes">&nbsp; </span>Cilj: Doktorska disertacija je koncipirana sa ciljem da se utvrdi uticaj toksičnog jedinjenja aristolohične kiseline I na histopatolo&scaron;ke i imunohistohemijske karakteristike tubulointersticijuma i glomerula bubrega kod mi&scaron;eva, kao i na biohemijske parametre krvi i urina koji ukazuju na o&scaron;tećenje bubrega. Materijal i metode: U ekperimentu je kori&scaron;ćeno 64 mi&scaron;a soja NMRI koji su podeljeni u tri grupe: eksperimentalna grupa (n=32) koja je dobijala aristolohičnu kiselinu I rastvorenu u polietilen glikolu (2,5% PEG 400) u dozi od 10 mg/kg telesne mase, negativna kontrolna grupa koja je dobijala 2,5% PEG 400 (n=16) i kontrolna grupa koja je dobijala fiziolo&scaron;ki rastovor (n=16). Sve životinje su tretirane intraperitonealno svakodnevno tokom sedam dana. Tokom eksperimenta 8., 17., 29. i 59. dana sakupljan je dvadesetčetvoročasovni urin 8 životinja iz eksperimentalne grupe, 4 životinje iz negativne kontrolne i 4 životinje iz kontrolne grupe. Životinje su žrtvovane 9., 18., 30. i 60. dana, uzeta im je krv, dok su bubrezi posebno odvojeni radi histopatolo&scaron;ke analize. Na bubrežnom tkivu sprovedene su histohemijske, imunohistohemijske i morfometrijske analize, dok su na uzorcima seruma i urina sprovedene biohemijske analize. Dobijeni rezultati su testirani adekvatnim statističkim metodama i prikazani su tabelarno i grafički. Rezultati: Nefrotoksin aristolohična kiselina I nakon 7 dana aplikacije izaziva značajno o&scaron;tećenje bubrežnog parenhima. Pri aplikaciji 2,5% PEG 400 i fiziolo&scaron;kog rastvora ne dolazi do vidljivog o&scaron;tećenja bubrežnog parenhima. Histopatolo&scaron;ku sliku u ranoj fazi eksperimenta (9. i 18. dan) karakteri&scaron;e akutna tubulska nekroza proksimalnih tubula. U kasnijoj fazi (30. i 60. dana) uočava se histopatolo&scaron;ka slika hroničnog intersticijalnog nefritisa sa obilnim mononuklearnim ćelijskim infiltratima limfocitnog porekla kao i postojanje blage intersticijalne fibroze. Kod eksperimentalnih životinja je morfometrijskim metodama utvrđen veći stepen bubrežnog o&scaron;tećenja tubulointersticijuma i smanjen broj podocita u glomerulu u odnosu na kontrolne grupe. Biohemijske analize kod većine eksperimentalnih životinja su pokazale veće koncentracije serumske uree nego kod kontrolnih grupa. Takođe je dokazana albuminurija u kasnijoj fazi eksperimenta koja je veća kod životinja izloženih aristolohičnoj kiselini I nego kod životinja iz kontrolnih grupa. Zaključak: Kori&scaron;ćenjem morfometrijskih metoda u okviru histopatolo&scaron;kih i imunohistohemijskih ispitivanja, uz adekvatne biohemijske analize, može se zaključiti da je aristolohična kiselina I izuzetno nefrotoksično jedinjenje koje izaziva izrazite<span style="mso-spacerun:yes">&nbsp; </span>promene tubulointersticijuma i glomerula. Podaci ovog istraživanja predstavljaju polaznu osnovu za dalja istraživanja dijagnostike u ranoj fazi nefropatija izazvanih aristolohičnim kiselinama.<span style="mso-spacerun:yes">&nbsp; </span></p> / <p>Introduction: Aristolochic acid I is a nephrotoxic and carcinogenic substance responsible for nephropathy caused by the use of herbal preparations and teas for slimminng regimen. Since this substance can be found in plants, it is considered one of the major ecotoxicological causes for the emergence of balkan endemic nephropathy whose definitive cause has not yet been revealed. The toxicity of this substance has been proven on numerous animal models, but pathophysiological mechanisms of kidney injury still remain unclear. Aim: The doctoral dissertation was designed to determine the influence of aristolochic acid on the histopathological and immunohistochemical characteristics of tubulointerstitium and glomerulus in mice, as well as the biochemical parameters of blood and urine that indicate kidney injury. Material and methods: For this study, 64 mouse of NMRI strain is used. They are divided into three groups: an experimental group (n=32) that received aristolochic acid I dissolved in polyethylene glycol (2.5% PEG 400) at a dose of 10 mg/kg of body weight, a negative control group that received 2.5% PEG 400 (n=16) and a control group that received only saline (n=16). All animals were treated intraperitoneally daily for seven days. During the experiment on the 8th, 17th, 29th and 59th day, twenty-four-hour urine was collected from 8 animals from the experimental group, 4 animals from the negative control and 4 animals from the control group. Animals were sacrificed on the 9th, 18th, 30th and 60th days, their blood was taken, while the kidneys were taken for histopathological analysis. Histochemical, immunohistochemical and morphometric analyzes were performed on renal tissue, while biochemical analyzes were performed on serum and urine samples. Obtained results were tested with adequate statistical methods and presented in a tables and graphs. Results: After 7 days of application nefrotoxin aristolochic acid I causes significant kidney injury. After application of 2.5% PEG 400 and saline, there was no visible damage to kidney parenchyma. Histopathological changes at the early stage of the experiment (9th and 18th day) were characterized by acute tubular necrosis of proximal tubules. At a later stage (30th and 60th day), chronic interstitial nephritis was observed in kidneys, with abundant mononuclear cell infiltrates in interstitium and presence of mild interstitial fibrosis. In experimental animals, a higher tubulointerstitial score of kidney injury and a decrease in the number of the podocytes in glomerulus were determined by morphometric methods, compared to the control groups. Biochemical analyzes in most experimental animals showed higher blood urea nitrogen concentrations than in control groups. High concentration of albumin in urine can be found in later stages of the experiment, and those concentrations were higher in animals exposed to aristolochic acid I than in animals from control groups.&nbsp; Conclusion: Using morphometric, histopathological and immunohistochemical methods, with adequate biochemical analysis, aristolochic acid I is proven to be an extremely nephrotoxic compound that causes drastic changes in tubulointerstitium and glomeruli of kidney parenhyma. Data from this study can be used for further research into early diagnosis of aristolochic acid nephropathy.</p>

<p>Karcinom bronha najče&scaron;ći uzrok smrti među malignim bolesti u svetu. U XX veku je registrovan značajan porast kako incidence, tako i mortaliteta karcinoma bronha u većini zemalja. Medijana preživljavanja u svim stadijumima bolesti se značajno pobolj&scaron;ala poslednjih godina XX veka, ali nedovoljno u odnosu na očekivano. U najvećem broju slučajeva, bolest se otkriva u uznapredovalom stadijumu, kada je radikalno hirur&scaron;ko lečenje kao optimalan vid lečenja nemoguće. Neodjuvantna terapija kod bolesnika sa lokalno uznapredovalim karcinomom pluća i zahvaćenim N2 limfnim čvorovima jedan je od modusa multimodalnog lečenja bolesnika sa nemikrocelularnim karcinomima pluća (NSCLC) u cilju pobolj&scaron;anja ishoda njihovog lečenja. Ovakav pristup podrazumeva prevođenje pacijenta iz vi&scaron;eg u niži stadijum bolesti - &bdquo;downstaging&rdquo;. Na taj način pacijent postaje potencijalno resektabilan u smislu daljeg hirur&scaron;kog lečenja koji bi mogao da obezebedi sveukupni onkolo&scaron;ki benefit. Osnovni ciljevi ove doktorske disertacije su bili: procena odgovora na neoadjuvantnu terapiju kod bolenika sa IIIA stadijumom nemikrocelularnog karcinoma bronha u odnosu na T faktor i N faktor, procena TNM klasifikacije pre i posle primenjene neoadjuvantne terapije kod bolesnika sa IIIA stadijumom nemikrocelularnog karcinoma bronha, određivanje stepena tumorske regresije patohistolo&scaron;kom analizom hirur&scaron;kog resekata nemikrocelularnog karcinoma bronha operisanih bolesnika nakon primenjene neoadjuvantne terapije, kao prognostički faktor za period bez bolesti i ukupnog preživljavanja i određivanje stepena regresije tumora u maligno izmenjenim limfnim čvorovima nakon primenjene neoadjuvantne terapije kod bolesnka sa IIIA stadijumom nemikrocelularnog karcinoma bronha, kao prognostički faktor za period bez bolesti i ukupnog preživljavanja.Rezultati su pokazali da neoadjuvantna terapija prema RECIST kriterijumima dovodi značajnog smanjenja veličine tumora, T faktora, kao i do znčajnog downstaging&ldquo;-a nodalnog statusa, N faktora, u terapiji bolesnika sa IIIA stadijumom nemikrocelularnog karcinoma bronha. Neoadjuvantna terapija prema RECIST kriterijumima dovodi značajnog smanjenja klinikog stadijuma bolesti, u terapiji bolesnika sa IIIA stadijumom nemikrocelularnog karcinoma bronha Nakon primenjene neoadjuvantne terapije nema značajne razlike u T faktoru koji je određen radiolo&scaron;ki prema RECIST kriterijumima (ycT) i patohistolo&scaron;ki (ypT) na hirur&scaron;kom materijalu. Nakon primenjene neoadjuvantne terapije prisutna je značajna razlika u N faktoru koji je određen radiolo&scaron;ki prema RECIST kriterijumima (ycN) i patohitolo&scaron;ki (ypN) na hirur&scaron;kom materijalu. Nakon primenjene neoadjuvantne terapije prisutna je značajna razlika u kliničkom stadijumu bolesti koji je određen radiolo&scaron;ki prema RECIST kriterijumima (yc) i patohitolo&scaron;ki (yp) na hirur&scaron;kom materijalu. Gradusi tumorske regresije su usko povezani sa procentom očuvanog tumorskog tkiva. Stepen tumorske regresije u resekatu primarnog tumora nije u korelaciji sa ukupnim preživljavanjem i procenom perioda bez bolesti kod pacijenata sa IIIA stadijumom nemikrocelularnog karcinoma bronha.</p> / <p>Lung cancer is the most common cause of death among malignant diseases in the world. In the twentieth century was a significant increase in both incidence and mortality of lung cancer in most countries. Median survival in all stages of the disease has improved significantly in recent years of the twentieth century, but not as we expected. In most cases, the disease is detected at an advanced stage, when the radical surgical treatment is considered impossible. Neoadjuvant therapy, in patients with locally advanced carcinoma of the lung, and with affected the lymph nodes N2, is one of the modes of multimodal treatment of patients with non-small cell lung cancer (NSCLC) in order to improve the outcome of their treatment. This involves translating the patient from a higher to a lower stage of the disease - &quot;downstaging&quot;. In this way the patient is considered for further surgical treatment that could provide him overall oncology benefit. Main objectives of this PhD dissertation are: evaluation of response to neoadjuvant therapy in stage IIIA NSCLC patients in relation to T factor and N factor; evaluation of TNM classification before and after use of neoadjuvant therapy in stage IIIA NSCLC patients; determination of degree of tumor regression with pathohistologic analysis of resection specimen of NSCLC obtained from patients after application of neoadjuvant therapy, as a prognostic factor for disease-free period and overall survival rate; and determination of degree of tumor regression in malignant lymph nodes after application of neoadjuvant therapy in stage IIIA NSCLC patients, as a prognostic factor for disease-free period and overall survival rate. Results have shown that neoadjuvant therapy according to RECIST criteria leads to significant reduction of tumor size, T factors, as well as significant downstaging of nodal status, N factor, in treatment of stage IIIA NSCLC patients. Furthermore, neoadjuvant therapy according to RECIST criteria leads to significant reduction of clinical stage of the disease in treatment of stage IIIA NSCLC patients. However, after neoadjuvant therapy is applied there is no significant difference in T factor determined radiologically according to RECIST criteria (ycT) and by pathohistologic analysis (ypT) of resected specimen. Neoadjuvant therapy leads to significant difference in N factor which is determined radiologically according to RECIST criteria (ycN) and by pathohistologic analysis (ypN) of resection specimen. After neoadjuvant therapy is applied there is significant difference in clinical stage of the disease determined radiologically according to RECIST criteria (yc) and by pathohistologic analysis (yp) of resection specimen. Tumor regression grading is closely linked to the percentage of preserved tumor tissue. Degree of tumor regression in surgical resection of primary tumor does not correlate to the overall survival rate and estimation of disease-free period in stage IIIA NSCLC patients.</p>

<p>Uvod: Virusni gastrointestinalni sindrom je aktuelni zdravstveni problem u celom svetu. To važi kako u razvijenim zemljama, tako i u zemljama u razvoju, a posebno u nerazvijenim zemljama, gde je drugi po redu uzrok mortaliteta. Nagli početak bolesti, praćen pojavom velikog broja tečnih stolica, mukom, povraćanjem, bolovima u stomaku, temperaturom, malaksalo&scaron;ću, ima za posledicu dehidrataciju. U svim starosnim grupama obolelih, a naročito kod sasvim male dece, starih i imunodeficitarnih osoba može da dođe do smrtnog ishoda, ukoliko se brzo ne postavi tačna etiolo&scaron;ka dijagnoza bolesti i ne pristupi se odmah nadoknadi vode i elektrolita, kao i primeni svih ostalih mera simptomatske terapije. Brzo postavljena tačna dijagnoza, &scaron;to se najbolje postiže real-time PCR testom, sprečava pojavu komplikacija, pa i fatalnog ishoda bolesti. Istovremeno, omogućava primenu odgovarajućih epidemiolo&scaron;kih mera da se spreči nastanak epidemija i njihovo &scaron;irenje. Cilj ovog istraživanja bio je da se tačno utvrdi incidenca virusnog gastrointestinalnog sindroma u Vojvodini i učestalost pojave epidemijskog i sporadičnog javljanja ove bolesti. Cilj je bio i postavljanje algoritma za primenu real-time PCR testa u dijagnostici virusnog gastrointestinalnog sindroma u budućem radu. Isto tako, cilj je bio da se molekularnom analizom, sekvenciranjem delova genoma pozitivnih uzoraka stolice, izvr&scaron;i genetska tipizacija i odredi filogenetska pripadnost virusa. Materijal i metode: Tokom petogodi&scaron;njeg istraživanja molekularnim real-time PCR testom pregledane su 1003 obolele osobe sa simptomima virusnog dijarealnog sindroma, starosti od mesec dana do preko 90 godina. Pregledani su na rota, noro, astro i enterične adenoviruse. Na osnovu podataka iz anketnih upitnika i istorija bolesti, detaljno su analizirani svi klinički pokazatelji (javljanje bolesti tokom godine, trajanje bolesti, simptomi). Procena težine kliničke slike vr&scaron;ena je prema Vesikari skali. Svi podaci su upoređivani prema vrsti virusnog uzročnika, prema starosti obolelih, godinama trajanja istraživanja i epidemijskom i sporadičnom javljanju oboljenja. Dobijeni podaci su statistički obrađeni, tabelarno i grafički prikazani. Rezultati: U petogodi&scaron;njem periodu real-time PCR testom pregledan je uzorak od 1003 obolele osobe različite starosti na 4 virusna uzročnika dijarealnog sindroma (rota, noro, astro i enterične adenoviruse). Virusni dijarealni sindrom dokazan je kod 709 obolelih (70,69%). Najče&scaron;će su dokazane rotavirusne infekcije u 28,81%. Statistički značajno najče&scaron;će rotavirusi su bili utvrđeni kod dece do 5 godina (38,90%), ali u visokom procentu i kod dece uzrasta 6 do 14 godina (24,83%). Deca mlađa od 5 godina imala su statistički značajno najtežu kliničku sliku, bila su če&scaron;će hospitalizovana i imala su statistički značajno vi&scaron;u temperaturu. Pored vi&scaron;e temperature kod obolelih od rotavirusa, klinička slika je kod ovih bolesnika bila teža i bolest je duže trajala nego kod obolelih od drugih virusa. Norovirusna infekcija je dokazana u 23,03% obolelih i to statistički značajno če&scaron;će kod odraslih osoba, starijih od 20 godina. Od kliničkih simptoma kod ovih bolesnika statistički značajno če&scaron;će su dokazani muka, povraćanje i bolovi u stomaku, nego kod obolelih od drugih virusa. Norovirusi su značajno če&scaron;će bili uzročnici epidemijskog javljanja bolesti. Astrovirus je dokazan kod znatno manjeg broja obolelih (u 2,29%) i to samo kod dece do 5 godina i dece uzrasta 6 do 14 godina. Infekcija izazvana enteričnim adenovirusima dokazana je kod 13,36% bolesnika. Njače&scaron;će je utvrđena kod dece uzrsta do 5 godina i 6 do 14 godina. Oboleli od adenovirusa imali su statistički značajno blažu kliničku sliku bolesti. Dva virusna uzročnika u uzorku stolice dokazana su u 3,19% osoba, obično u toku epidemijskog javljanja bolesti. Ovi bolesnici su imali bitno težu kliničku sliku. Najvi&scaron;e obolelih od dijarealnog sindroma bilo je u hladnim mesecima, mada su dijagnostikovani i tokom cele godine. U petogodi&scaron;njem periodu utvrđene su 22 epidemije u kolektivima i 9 porodičnih epidemija. Epidemijsko javljanje bolesti bilo je statistički značajno najče&scaron;će kod najstarijih bolesnika (starijih od 50 godina), a sporadično javljanje bilo je statističko značajno najče&scaron;će kod dece. U cilju potvrde tačnosti dijagnostike virusa u ispitivanim uzorcima real-time PCR testom, genotipizacije, kao i detaljnije molekularne analize, izabrani su reprezentativni uzorci pozitivni na rota, noro, astro ili adenoviruse. Delovi genoma ovih uzoraka su amplifikovani, a zatim sekvencirani. Sekvencirani izolati rotavirusa pripadali su grupi A i tipovima G1P[8], G2P[4], G3P[8] i G9P[8]. Sekvencirani izolati norovirusa pripadali su genogrupi I tipu 2, zatim genogrupi II tipovima 1, 2, 4 i 17. Sekvencirani izolati astrovirusa pripadali su grupi klasičnih astrovirusa i tipovima 1, 4 i 5. Sekvencirani izolati adenovirusa pripadali su grupi F i tipovima 40 i 41, kao i grupi C tipu 2. Pripadnost dobijenih sekvenci u ovom istraživanju, dodatno je potvrđena izradom filogenetskog stabla za sekvence pozitivne na rota, noro, astro ili adenoviruse. Zaključak: Incidenca virusnog dijarealnog sindroma u Vojvodini (70,69%) vrlo je visoka i vi&scaron;a je nego &scaron;to je bilo pretpostavljeno prilikom prijave teze (u hipotezi). Real-time PCR test treba da bude redovno kori&scaron;ćen u budućem dijagnostičkom radu, jer dovodi do brze dijagnostike, čak i ako su virusi prisutni u malom broju u uzorcima tečnih stolica, &scaron;to je utvrđeno tokom ovog dijagnostičkog rada. Ispitivani virusi treba da budu redovno dijagnostikovani kod obolelih od dijarealnog sindroma i to u svim starosnim grupama, tokom epidemijskog i sporadičnog javljanja oboljenja.</p> / <p>Introduction: Viral gastrointestinal syndrome is a current ongoing health problem worldwide. This is true of both developed and developing countries, especially underdeveloped ones where it is the second leading cause of mortality. Sudden onset of the disease&mdash;accompanied by the occurrence of large numbers of liquid stools, nausea, vomiting, abdominal pain, fever, and exhaustion&mdash;leads to dehydration. A fatal outcome can occur in all age groups of patients, especially very young children, the elderly, and the immuno-deficient, unless an accurate etiological diagnosis of the disease is quickly established, followed by a prompt institution of fluid and electrolyte placement, and implementation of other symptomatic therapy measures. Quick establishment of an accurate diagnosis, which is best achieved using the real-time PCR test, prevents the onset of complications, including a potentially fatal outcome of the disease. Simultaneously, it enables the implementation of appropriate epidemiological measures to prevent epidemic outbreaks and their spread. The aim of this study was to accurately determine the incidence of viral gastrointestinal syndrome in Vojvodina and the frequency of epidemic and sporadic occurrence of this disease. The aim was also to set up an algorithm for the application of the real-time PCR test in diagnostics of viral gastrointestinal syndrome in future work. Likewise, the aim was to carry out genetic typing and determine phylogenetic affiliation of the virus using molecular analysis and sequencing of parts of genomes from positive stool samples. Material and Methods: During a five-year study, 1003 patients with symptoms of viral diarrheal syndrome, aged from one month to more than 90 years old, were examined using molecular real-time PCR test. They were screened for rota, noro, astro, and enteric adenoviruses. Based on the data from survey questionnaires and medical case history, all clinical indicators were meticulously analyzed (disease occurrence during the year, disease duration, symptoms). The assessment of the clinical severity was carried out according to the Vesikari Clinical Severity Scoring scale. All data were compared according to the type of the viral causing agent, age of the patients, duration of research in years, and epidemic and sporadic occurrence of the disease. Obtained data were statistically analyzed, tabulated, and graphically displayed. Results: In a five-year period, a sample of 1003 patients of different ages was screened for four different viral causing agents of diarrheal syndrome (rota, noro, astro, and enteric adenoviruses) using the real-time PCR test. Viral diarrheal syndrome was confirmed in 709 patients (70.69%). The most commonly found were rotavirus infections in 28.81% of the cases. Rotaviruses were statistically significantly most common in children younger than 5 years old (38.90%), but were also found in high percentage in children aged 6-14 years old (24.83%). Children under 5 years of age had statistically significantly highest clinical severity and fever, and were more frequently hospitalized. In addition to higher fever in patients with rotavirus, clinical severity in these patients was also higher, and the disease lasted longer than in patients with other viruses. Norovirus infections were reported in 23.03% of the subjects, statistically significantly more frequently in adults over 20 years of age. Regarding the clinical symptoms in these patients, nausea, vomiting, and abdominal pain were statistically significantly more common than in patients with other viruses. Noroviruses were significantly more common as causing agents of epidemic disease outbreaks. Astrovirus was found in a significantly smaller number of patients (in 2.29%), and only in children under 5 years of age and children aged 6-14 years old. Enteric adenovirus infections were reported in 13.36% of the subjects. They were most commonly found in children younger than 5, and those aged 6- 14 years old. Adenovirus sufferers had statistically significantly milder clinical disease. Two viral causing agents in the stool sample were found in 3.19% of the subjects, usually during an epidemic disease outbreak. These patients had a significantly more severe clinical disease. Highest numbers of sufferers from diarrheal syndrome occurred during the cold months, although they were diagnosed throughout the year. In a five-year period, 22epidemics in collective groups and 9 family epidemics were identified. Epidemic outbreaks of the disease were statistically significantly most frequent in the elderly patients (older than 50), while sporadic occurrences were statistically significantly most frequent in children. Representative samples positive for rota, noro, astro, or adenoviruses were selected in order to confirm the accuracy of virus diagnostics in samples tested by the real-time PCR test, and perform genotyping as well as more detailed molecular analyses. Parts of the genomes of these samples were amplified and then sequenced. Sequenced rotavirus isolates belonged to group A and types G1P[8], G2P[4], G3P[8], and G9P[8]. Sequenced norovirus isolates belonged to genogroup I type 2, and genogroup II types 1, 2, 4, and 17. Sequenced astrovirus isolates belonged to the group of classical astroviruses and types 1, 4, and 5. Sequenced adenovirus isolates belonged to group F and types 40 and 41, as well as group C type 2. The affiliation of the obtained sequences in this study was further confirmed by creating a phylogenetic tree for sequences positive for rota, noro, astro, or adenoviruses. Conclusion: The incidence of viral diarrheal syndrome in Vojvodina (70.69%) is very high&mdash;higher than what was assumed at the time of the thesis submission (in the hypothesis). The real-time PCR test should be regularly used in future diagnostic work, since it leads to rapid diagnostics even if viruses are present in small numbers in liquid stool samples, as determined in the course of this diagnostic study. The investigated viruses should be regularly tested in patients with diarrheal syndrome belonging to all age groups during both epidemic and sporadic occurrences of the disease.</p>

<p>Značajan porast prevalence dentalnih erozija u savremenom dru&scaron;tvu, zahteva sve vi&scaron;e pažnje ka&nbsp; istraživanju njihove etiologije i preventivnih mera koje se mogu preduzeti. Cilj ove studije bio je da se ispita erozivni potencijal gaziranih napitaka i njihov uticaj na zubna tkiva, tokom različitih vremenskih intervala.<br />Stepen kiselosti izražen pH vrednostima za svaki ispitivani napitak (gaziranu vodu &bdquo;Knjaz Milo&scaron;&ldquo;, Coca-Cola-u i Schweppes Bitter Lemon), određen je odmah po otvaranju ambalaže sa napitkom, nakon 5 i 60 minuta kao i nakon 12 i 24 sata od potapanja zubnih uzoraka. U ovoj studiji posmatrane su mikroskopske promene proučavanjem skening elektronske mikrofotografije spolja&scaron;nje povr&scaron;ine gleđi, kao i uzdužni presek gleđi i dentina zuba nakon izlaganja gore navedenim napicima 5 i 60 minuta,12 i 24 sata kao i 7 i 30 dana, ali i makroskopske promene boje i strukture gleđi u svim navedenim vremenskim intervalima. Za određivanje stepena nastalih mikroskopskih i makroskopskih promena primenjene su individualno prilagođene skale.<br />Početna pH vrednost svih ispitivanih napitaka je niža od kritične pH vrednosti za demineralizaciju gleđi. Sa porastom vremena od potapanja zubnih uzoraka u napitke, njihova pH vrednost značajno raste. Na SEM mikrofotografijama gleđi i dentina se uočavaju promene u morfologiji, čiji intenzitet zavisi od vrste napitka i vremena koje je uzorak u njemu proveo. Centralni tip demineralizacije prisutan je kod uzoraka potopljenih u kiselu vodu i Coca Cola napitak a periferni kod Schweppes Bitter Lemon. Intenzitet promena zubnih tkiva raste u funkciji vremena, ali statistički značajna razlika ne postoji između svih vremenskih intervala. Zubi koji su bili izloženi delovanju gazirane vode &bdquo;Knjaz Milo&scaron;&ldquo; ne pokazuju izmene u makroskopskom izgledu, za razliku od zuba koji su tretirani Coca-Cola-om i Schweppes Bitter Lemon-om čiji intenzitet izmenjenosti raste u funkciji vremena, s tim da je statitički značajna razlika prisutna između pojedinih vremenskih intervala. S obzirom na erozivni potencijal i promene koje gazirani napitci izazivaju u in vitro условима, potrebno je preduzeti odgovarajuće preventivne mere kako bi se smanjio njihov uticaj na zube u in vivo uslovima.</p> / <p>Značajan porast prevalence dentalnih erozija u savremenom dru&scaron;tvu, zahteva sve vi&scaron;e pažnje ka&nbsp; istraživanju njihove etiologije i preventivnih mera koje se mogu preduzeti. Cilj ove studije bio je da se ispita erozivni potencijal gaziranih napitaka i njihov uticaj na zubna tkiva, tokom različitih vremenskih intervala.<br />Stepen kiselosti izražen pH vrednostima za svaki ispitivani napitak (gaziranu vodu &bdquo;Knjaz Milo&scaron;&ldquo;, Coca-Cola-u i Schweppes Bitter Lemon), određen je odmah po otvaranju ambalaže sa napitkom, nakon 5 i 60 minuta kao i nakon 12 i 24 sata od potapanja zubnih uzoraka. U ovoj studiji posmatrane su mikroskopske promene proučavanjem skening elektronske mikrofotografije spolja&scaron;nje povr&scaron;ine gleđi, kao i uzdužni presek gleđi i dentina zuba nakon izlaganja gore navedenim napicima 5 i 60 minuta,12 i 24 sata kao i 7 i 30 dana, ali i makroskopske promene boje i strukture gleđi u svim navedenim vremenskim intervalima. Za određivanje stepena nastalih mikroskopskih i makroskopskih promena primenjene su individualno prilagođene skale.<br />Početna pH vrednost svih ispitivanih napitaka je niža od kritične pH vrednosti za demineralizaciju gleđi. Sa porastom vremena od potapanja zubnih uzoraka u napitke, njihova pH vrednost značajno raste. Na SEM mikrofotografijama gleđi i dentina se uočavaju promene u morfologiji, čiji intenzitet zavisi od vrste napitka i vremena koje je uzorak u njemu proveo. Centralni tip demineralizacije prisutan je kod uzoraka potopljenih u kiselu vodu i Coca Cola napitak a periferni kod Schweppes Bitter Lemon. Intenzitet promena zubnih tkiva raste u funkciji vremena, ali statistički značajna razlika ne postoji između svih vremenskih intervala. Zubi koji su bili izloženi delovanju gazirane vode &bdquo;Knjaz Milo&scaron;&ldquo; ne pokazuju izmene u makroskopskom izgledu, za razliku od zuba koji su tretirani Coca-Cola-om i Schweppes Bitter Lemon-om čiji intenzitet izmenjenosti raste u funkciji vremena, s tim da je statitički značajna razlika prisutna između pojedinih vremenskih intervala. S obzirom na erozivni potencijal i promene koje gazirani napitci izazivaju u in vitro uslovima, potrebno je preduzeti odgovarajuće preventivne mere kako bi se smanjio njihov uticaj na zube u in vivo uslovima.</p> / <p>Due to the fact that prevalence of dental erosion significantly increased in modern society, it is important to investigate its etiological factors and all available preventive measures. The aim of this study was to investigate erosive potential of carbonated beverages and their influence on dental hard tissues, during different intervals.<br />The acidity or pH level was measured for each beverage (carbonated water &bdquo;Knjaz Milos&ldquo;, Coca-cola and Schweppes Bitter Lemon), on opening of the bottle, after 5 minutes and 60 minutes, and after 12 hours and 24 hours immersion of tooth samples in adequate beverage. In this study, microscopic changes of dental tissues were examined using a scanning electron microphotography of outer surface of enamel and longitudinal section of enamel and dentin, after exposure to beverages during 5 and 60 minutes, 12 and 24 hours, and 7 and 30 days, as well as macroscopic changes of tooth color and structure at same intervals. Individually adopted scales were used for grading of the severity of microscopic and macroscopic changes.<br />Initiated pH value of each tested beverage was lower than critical pH for enamel demineralisation. SEM images of enamel and dentin showed different morphology changes, which intensivity depended on type of beverages and time that sample were stored. Central type of demineralisation was visible on samples treated with carbonated water and Coca-Cola, while peripheral type of demineralisation was detected on samples treated with Schweppes Bitter Lemon. The intensity of alterations of dental tissues increased during time, but there was not statistically significant difference between all intervals. There wasn&rsquo;t detected macroscopic changes on teeth stored in carbonated water, while teeth treated with Coca-Cola and Schweppes Bitter Lemon showed changes which intensity increased during time, but statistically significant difference between all intervals wasn&rsquo;t detected. Due to erosive potential and changes influenced by carbonated beverages in vitro, preventive measures are necessary for reducing their effect on teeth in vivo.</p>

<p>Cilj ove doktorske disertacije je bio odrediti niz tehnolo&scaron;kih postupaka koji bi omogućili iskori&scaron;ćenje sremu&scaron;a u prehrambene i farmaceutske svrhe u svežem ili suvom stanju, kao biljne droge za pripremu različitih formi ekstrakata bogatih bioaktivnim jedinjenjima izolovanih iz njega.<br />List sremu&scaron;a bere se u vrlo kratkom vremenskom periodu tokom proleća, a nakon branja njegovi listovi vrlo brzo venu i gube svoja senzorna, nutritivna i funkcionalna svojstva, zbog čega je dostupnost ove biljne sirovine vremenski vrlo ograničena. Zbog toga su ispitani uslovi skladi&scaron;tenja svežeg lista sremu&scaron;a kako bi se sagledala trajnost sremu&scaron;a za konzumiranje u svežem stanju, ali i mogućnost primene skladi&scaron;tenog sremu&scaron;a za ekstrakciju bioaktivnih jedinjenja. Za dobijanje osu&scaron;enog lista sremu&scaron;a ispitan je uticaj različitih tehnika su&scaron;enja (konvektivno i vakuumsko su&scaron;enje) i temperature su&scaron;enja (40, 50, 60 i 70 &deg;C) na sadržaj bioaktivnih komponenti u osu&scaron;enom proizvodu. Primenom odgovarajuće tehnike su&scaron;enja, povećava se stabilnost i dostupnost listova sremu&scaron;a za potrebe prehrambene i farmaceutske industrije. Primenom savremenih ekstrakcionih tehnika kao &scaron;to je ekstrakcije superkritičnim ugljen-dioksidom, ekstrakcije subkritičnom vodom i ultrazvučne ekstrakcije, ispitan je uticaj procesnih parametara različitih ekstrakcionih tehnika, poput ultrazvučne ekstrakcije (temperatura, vreme ekstrakcije, snaga ultrazvuka, uticaj rastvarača) i ekstrakcije subkritičnom vodom (temperatura, vreme ekstrakcije, dodatak modifikatora), superkritične ekstrakcije ugljen-dioksidom (pritisak i temperatura), dok je maceracija kao konvencionalna tehnika ekstrakcije primenjena za poređenje efikasnosti modernih ekstrakcionih postupaka. U dobijenim ekstraktima ispitan je sadržaj polifenolnih komponenti, antioksidantna aktivnost i sadržaj sumpornih jedinjenja u cilju optimizacije ekstrakcionih parametara i radi utvrđivanja uslova ekstrakcije pri kojima se postiže najveći kvalitet ekstrakata u pogledu sadržaja ciljanih bioaktivnih komponenti.&nbsp; Za odabrane ekstrakte ispitan je antimikrobni potencijal na različite Gram pozitivne i Gram negativne bakterijske sojeve. Za dobijanje stabilnijih formi odabranih ekstrakata primenjena je enkpasulacija spray drying i spray congeling tehnikom. Enkapsuliranim ekstraktima su određene fizičko-hemijske osobine (hemijski sastav, sadržaj vlage, higroskopnost, moć rehidratacije, WAI i WSI) i biolo&scaron;ka aktivnost (antimikrobna i antioksidativna aktivnost).</p> / <p>The aim of this doctoral dissertation was to determine various technological procedures that would enable the use of fresh and dryed wild garlic leaves in foods and pharmaceutical industry, as a herbal drug or nutraceuticals.<br />The availability period of fresh wild garlic is very short and only during the spring season. After harvest, the leaves are quite perishable, wither very quickly and lose their sensory, nutritive and functional properties. This makes the availability time of this herbal raw material very limited. Therefore, the conditions for storing the fresh leaves of wild garlic and the influences of storing conditions on composition of bioactive compounds were examined in order to extend their use in fresh state. In order to obtain dry herbal drug for extraction, influence of various drying techniques (convection and vacuum drying) and drying temperatures (40, 50, 60, 70 &deg;C) were examinated. The stability and availability of wild garlic in food and pharmaceutical industries was extended by drying. The influence of process parameters of different modern extraction techniques - ultrasonic extraction (temperature, extraction time, ultrasonic power, solvent effect) and subcritical water extraction , extraction time, modifier addition), supercritical carbon dioxide extraction (pressure and temperature) - was examined, while maceration (as a conventional extraction technique) was used to evaluate the efficiency of modern extraction methods. The obtained extracts were analysed in terms of the polyphenolic content, the antioxidant activity and the content of sulfur compounds in order to optimize the extraction parameters and determine the extraction conditions for achieving the highest quality of extracts in terms of the content of the target bioactive components. Antimicrobial potential for different Gram positive and Gram negative bacterial strains was tested for selected<br />extracts. To obtain more stable forms of selected extracts encapsulation techniques - spray drying and spray congeling - were applied. Encapsulated extracts were evaluated in terms of physico-chemical properties (chemical composition, moisture content, hygroscopicity, rehydration power, WAI and WSI) and biological activity (antimicrobial and antioxidant activity).</p>

An der TU Chemnitz haben sich seit über zwei Jahrzehnten die Gebiete der rechnergestützten Wissenschaften (Computational Science) sowie des parallelen und verteilten Hochleistungsrechnens mit zunehmender Verzahnung entwickelt. Die Koordinierung und Bündelung entsprechender Forschungsarbeiten in der Profillinie 6 “Modellierung, Simulation, Hochleistungsrechnen” wird es ermöglichen, im internationalen Wettbewerb des Wissens mitzuhalten.